Angioedema associated with dipeptidyl peptidase-IV inhibitors

BACKGROUND: Dipeptidyl peptidase-IV (DPP-IV) inhibitors, also known as gliptins, are a class of oral antidiabetic agents. Postmarketing reports have documented the occurrence of angioedema in patients treated with gliptins and it was found that these drugs increased the risk of angioedema in patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Cassano, Nicoletta, Nettis, Eustachio, Di Leo, Elisabetta, Ambrogio, Francesca, Vena, Gino A., Foti, Caterina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8647342/
https://www.ncbi.nlm.nih.gov/pubmed/34872575
http://dx.doi.org/10.1186/s12948-021-00164-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8647342/
https://www.ncbi.nlm.nih.gov/pubmed/34872575
http://dx.doi.org/10.1186/s12948-021-00164-7

Ejemplares similares